menu
    • menu

    Company profile for Cyanvac

    NEW Drugs in Dev: 6
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cyanvac LLC is developing vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector. Our platform enables us to make robust, intranasal vaccines that are easy to administer, easy to transport, and easy to manufacture. Cyanvac LLC’s mission is to tackle the world’s most pressing infectious diseases with vaccines that can be easily delivered worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CyanvacUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    111 Riverbend Road, Athens, GA 30602
    Telephone
    Telephone
    (706) 201-7798
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cyanvacllc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Blue Lake, CyanVac Share Full COVID-19 Vax Phase 1 Data
    Blue Lake, CyanVac Share Full COVID-19 Vax Phase 1 Data

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707039979/en/Blue-Lake-and-CyanVac-Publish-Full-Data-from-Open-Label-Phase-1-Clinical-Study-of-COVID-19-Vaccine-Candidate

    BUSINESSWIRE
    07 Jul 2025
    Share Share
    1st Patient Dosed in Ph 2b Study of CyanVac's COVID-19 Vaccine
    1st Patient Dosed in Ph 2b Study of CyanVac's COVID-19 Vaccine

    09 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241209089413/en

    BUSINESSWIRE
    09 Dec 2024
    Share Share
    Blue Lake and CyanVac Present at Society for Vaccines Congress
    Blue Lake and CyanVac Present at Society for Vaccines Congress

    21 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241020038518/en

    BUSINESSWIRE
    21 Oct 2024
    Share Share
    CyanVac Receives BARDA-Funded Project NextGen Award Intranasal COVID-19
    CyanVac Receives BARDA-Funded Project NextGen Award Intranasal COVID-19

    13 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240613249656/en

    BUSINESSWIRE
    13 Jun 2024
    Share Share
    PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Response
    PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Response

    15 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240215790008/en

    BUSINESSWIRE
    15 Feb 2024
    Share Share
    CyanVac CEO Speaks at White House Summit on the Future of COVID-19 Vaccines
    CyanVac CEO Speaks at White House Summit on the Future of COVID-19 Vaccines

    27 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cyanvac-ceo-speaks-at-white-house-summit-on-the-future-of-covid-19-vaccines-301594133.html

    PRNEWSWIRE
    27 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search